Pay in 4 interest-free payments of $6.13 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Phase 3 TRIUMPH program ongoing Dosing / Once-weekly subcutaneous injection, studied at 1 mg to 12 mg Efficacy / 24.2% mean weight loss at 48 weeks with 12 mg dose in Phase 2 (N=338) Common side effects / Nausea, diarrhea, vomiting, constipation (mostly mild-to-moderate) Young-adult concern / Bone mineral density still accruing until age 25-30 Fertility note / No human fertility data
Health Library
Abdomen Thigh Upper arm You should rotate injection sites, so youre not administering the medication in the same location each time
MC1R is a class A GPCR that couples predominantly to Gs
& Moghaddam, B
If I notice certain symptoms or changes, which ones should prompt me to contact you and how quickly
US$ 28.88
US$ 29.42
US$ 22.41
US$ 28.09
US$ 21.62
